Clinical trial

CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

NCT07701590

Study summary

ClinicalTrials.gov

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Microlyte® Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention IP 1: Membrane Wrap - Hydro Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-22

PhaseNA

Conditions

Wound, Footunresolved

Diabetic Foot Ulcer (DFU)unresolved

Venus Leg Ulcerunresolved

Interventions

Microlyte®DEVICE

IP 1: Membrane Wrap - HydroDEVICE

Sponsors & collaborators

Capsicure, LLClead sponsor

BioLab Holdingscollaborator

Mapped research locations

MiamiFlorida, United States2 HoustonTexas, United States1 St LouisMissouri, United States1 San DiegoCalifornia, United States1 IndianapolisIndiana, United States1 Coral GablesFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07701590 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.